CEFYBO 02669
CENTRO DE ESTUDIOS FARMACOLOGICOS Y BOTANICOS
Unidad Ejecutora - UE
artículos
Título:
Insulin resistance and Polycystic Ovary Syndrome through life
Autor/es:
EVANTHIA DIAMANTI KANDARAKIS; POLI MARA SPRITZER; TERESA SIR PETERMANN; ALICIA BEATRIZ MOTTA
Revista:
CURRENT PHARMACEUTICAL DESIGN.
Editorial:
BENTHAM SCIENCE PUBL LTD
Referencias:
Año: 2012 vol. 18 p. 5569 - 5576
ISSN:
1381-6128
Resumen:
The heterogeneity of Polycystic Ovary Syndrome (PCOS) emphasizes the need for a consensual review the data concerning its diagnosis and treatment and for determination of the relationship between the development of PCOS and the ethnic origin, the social status and the lifespan. Insulin resistance is an important characteristic in women with PCOS that aggravates features of PCOS. This review is focused in the diagnosis and treatment of insulin resistance and the risk factors for PCOS during childhood, adolescence and post- menopause. The role of endocrine disruptors and/or their interaction with PCOS have also been analyzed.
